SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFR14A - Revised definitive proxy soliciting materials:
SEC Accession No. 0001144204-14-028261
Filing Date
2014-05-07
Accepted
2014-05-07 16:34:31
Documents
9
Effectiveness Date
2014-05-07

Document Format Files

Seq Description Document Type Size
1 DEFR14A v377225_defr14a.htm DEFR14A 901665
2 GRAPHIC line.gif GRAPHIC 43
3 GRAPHIC logo_novavax-tag.jpg GRAPHIC 17343
4 GRAPHIC logo_novavax.jpg GRAPHIC 19201
5 GRAPHIC sig_john-herrmann3.jpg GRAPHIC 4200
6 GRAPHIC sig_stanley-erck.jpg GRAPHIC 6086
7 GRAPHIC spacer.gif GRAPHIC 43
8 GRAPHIC v377225_pc1.jpg GRAPHIC 189549
9 GRAPHIC v377225_pc2.jpg GRAPHIC 126376
  Complete submission text file 0001144204-14-028261.txt   1403739
Mailing Address 20 FIRSTFIELD ROAD GAITHERSBURG MD 20878
Business Address 20 FIRSTFIELD ROAD GAITHERSBURG MD 20878 240-268-2000
NOVAVAX INC (Filer) CIK: 0001000694 (see all company filings)

IRS No.: 222816046 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFR14A | Act: 34 | File No.: 000-26770 | Film No.: 14821463
SIC: 2836 Biological Products, (No Diagnostic Substances)